Farallon Capital Management »

Precigen shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $209k 50k 4.18

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding Precigen

Patient Capital Management
BlackRock
Point72 Asset Management
State Street Corporation
Vanguard Group
Tang Capital Management
Geode Capital Management
Diametric Capital
Iridian Asset Management
Citadel Advisors
Goldman Sachs Group
Driehaus Capital Management
Northern Trust
Charles Schwab Investment Management
Woodline Partners

View all funds holding Precigen